Pharmacology effect of neurogenic inflammation

dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDepartment of Pharmacology and Pharmacotherapyhu_HU
dc.contributor.authorMatsuyama, Kyohhei
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentdeptKenézy Kórház, Aneszteziológiai és Intenziv Therápiás Osztályhu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.date.accessioned2022-01-19T12:24:59Z
dc.date.available2022-01-19T12:24:59Z
dc.date.created2021-11-05
dc.description.abstractInflammation is a common protective mechanism to remove initial cause of cell injury. In the nervous system, sensory nerves and leukocytes regulate inflammation by secretion of neuropeptides such as substance P and neurokinin A centrally and peripherally causing neurogenic inflammation. It causes several diseases in different organs: migraines, asthma, atopic dermatitis, and psoriasis. The pharmacology effect of neurogenic inflammation depends on the receptors located in the organs. A variety of drugs have now been developed and are effective against neurogenic inflammation.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent35hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/328036
dc.language.isoenhu_HU
dc.subjectneurogenic inflammationhu_HU
dc.subjectmigrainehu_HU
dc.subjectCGRP receptorshu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titlePharmacology effect of neurogenic inflammationhu_HU
Fájlok